Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX)

Int J Epidemiol. 2022 Jun 13;51(3):e123-e130. doi: 10.1093/ije/dyab231.

Wijnand Van Den Boom¹, Maria Del Mar Quiroga^{1

2}, Daniel O'Keefe^{1

3}, Dhanya Kumar^{1

3}, Penelope L Hill^{1

3}, Nick Scott^{1

3}, Paul A Agius^{1

3

4}, Peter Higgs^{1

5}, Thomas Kerr⁶, Lisa Maher^{1

7}, Matthew Hickman^{1

8}, Mark Stoové^{1

3}, Paul Dietze^{1

9}

¹ Behaviours and Health Risks, Burnet Institute, Melbourne, VIC, Australia.
² Melbourne Data Analytics Platform (MDAP), The University of Melbourne, Melbourne, Australia.
³ School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
⁴ Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
⁵ Department of Public Health, La Trobe University, Melbourne, VIC, Australia.
⁶ Division of Social Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
⁷ Kirby Institute for Infection and Immunity, UNSW, Sydney, NSW, Australia.
⁸ Population Health Sciences, University of Bristol, Bristol, UK.
⁹ National Drug Research Institute, Curtin University, Melbourne, VIC, Australia.

No abstract available

Publication types